MedTrace Logo

Prospective Evaluation Analysis and Kinetics Registry

NCT05247320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2023-09-26

No results posted yet for this study

Summary

In a cohort of patients electively treated for atrial arrhythmia with IV sotalol (initiation or dose escalation), this study will describe patient characteristics, short-term safety and efficacy, electrocardiographic monitoring, and PK and PD parameters (in a subset) associated with IV dosing approach.

Conditions

  • Atrial Arrhythmia

Interventions

DRUG

Sotalol Injection

Standard of care IV sotalol infusion for atrial arrhythmias

Sponsors & Collaborators

Principal Investigators

  • Benjamin A. Steinberg, MD, MHS · University of Utah

  • Jonathan Pinccini, MD · Duke University

  • Suneet Mittal, MD · Valley Health

  • Parash Pokharel, MD · Geisinger Health

  • Thomas F Deering, MD · Piedmont Heart Institute

  • Robert Kennedy, MD · Munson Medical Center

  • Michael West, MD · Presbyterian Healthcare Services

  • Sergio Cossu, MD · Lehigh Valley Health Network

  • Nishant Verma, MD · Northwestern University

  • Jonathan Silver, MD · Lahey Hospital & Medical Center

  • Abhishek Deshmukh, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2023-08-30
Completion
2023-08-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247320 on ClinicalTrials.gov